Macular Hole Progression following Ocriplasmin Intravitreal Injection

Macular Hole Progression following Ocriplasmin Intravitreal Injection

Saved in:

Bibliographic Details
Main Authors:	Edward Casswell, Guillermo Fernandez-Sanz, Danny Mitry, Sheila Luk, Rahila Zakir
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Case Reports in Ophthalmological Medicine
Online Access:	http://dx.doi.org/10.1155/2014/403461
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of a simple intravitreal perfluoropropane injection in treating unclosed idiopathic macular holes following vitrectomy
by: Zexia Dou, et al.
Published: (2025-02-01)

Contralateral Effect following Intravitreal Brolucizumab Injection in Diabetic Macular Edema
by: Somnath Chakraborty, et al.
Published: (2022-01-01)

Comparison of Guided and Unguided Ocriplasmin Injection for the Treatment of Vitreomacular Traction: A Preliminary Study
by: Rodolfo Mastropasqua, et al.
Published: (2016-01-01)

Full-Thickness Macular Hole Formation After Intravitreal Faricimab Injection for Polypoidal Choroidal Vasculopathy
by: Tavonvunchai F, et al.
Published: (2025-06-01)

Full Thickness Macular Hole Following Intravitreal Bevacizumab for A Vascularised Pigment Epithelial Detachment
by: Neha Goel
Published: (2021-04-01)

Efficacy and safety of prophylactic simultaneous intravitreal moxifloxacin injection with standard intravitreal anti-VEGF injection procedure in cases of cystoid macular edema and macular neovascularization
by: Mohamed Nagy Elmohamady, et al.
Published: (2025-05-01)

Intravitreal Injections for Macular Edema in Silicone Oil Filled Eyes
by: Safadi K, et al.
Published: (2024-11-01)

Efficacy of combining posterior scleral contraction and intravitreal C3F8 injection in high myopia with macular hole retinal detachment
by: Si Chen, et al.
Published: (2025-06-01)

Intravitreal bevacizumab injection alone or combined with macular photocoagulation compared to macular photocoagulation as primary treatment of diabetic macular edema
by: Jovanović Sandra, et al.
Published: (2015-01-01)

One-year results of visual response following intravitreal novel anti-VEGF injection for diabetic macular edema in a Latino population
by: Guillermo Salcedo-Villanueva, et al.
Published: (2025-08-01)

Efficacy and safety of intravitreal injection of aflibercept biosimilar for treating diabetic macular edema
by: Gaixia Zhai, et al.
Published: (2025-03-01)

Iatrogenic macular hole following PFCL injection: Implications of retinal dimpling as an intraoperative indicator
by: Aditya Kelkar, et al.
Published: (2024-12-01)

Patient Preferences with Regard to Laser versus Intravitreal Injections in the Treatment of Diabetic Macular Edema
by: Lauren Mason, et al.
Published: (2017-01-01)

Corrigendum: Efficacy and safety of intravitreal injection of aflibercept biosimilar for treating diabetic macular edema
by: Gaixia Zhai, et al.
Published: (2025-05-01)

Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema
by: Fatima Shafqat Khan, et al.
Published: (2023-12-01)

Resveratrol Supplementation in Wet AMD: Association With Fewer Intravitreal Injections and Reduced Macular Fibrosis
by: Datseris I, et al.
Published: (2025-01-01)

Acute Acanthamoeba panophthalmitis following intravitreal drug injection
by: Worawut Worawutwittaya, et al.
Published: (2025-01-01)

Effects of Intravitreal Ranibizumab Injection on Chinese Patients with Wet Age-Related Macular Degeneration: 5-Year Follow-Up Results
by: Yingyi Lu, et al.
Published: (2016-01-01)

Effect of Repeated Intravitreal Ranibizumab and Aflibercept Injections on the Cornea in Patients with Age-Related Macular Degeneration
by: Beata Urban, et al.
Published: (2020-01-01)

Real-world clinical insights and aqueous humor biomarker analysis of diabetic macular edema subtypes classified by OCT following intravitreal injections
by: Liangzhang Tan, et al.
Published: (2025-07-01)

Delayed-onset Moraxella nonliquefaciens endophthalmitis following intravitreal injection
by: Paul S. Micevych, et al.
Published: (2025-09-01)

Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema.
by: Ahmed Abdel-Hay, et al.
Published: (2018-01-01)

Risk factors for emerging intraocular inflammation after intravitreal brolucizumab injection for age-related macular degeneration.
by: Ryo Mukai, et al.
Published: (2021-01-01)

Diabetic Macular Edema in Maintenance Intravitreal Scheduling
by: Enzo Maria Vingolo, et al.
Published: (2025-05-01)

Changes in Aqueous Humor Cytokine Profile Following Intravitreal Brolucizumab Injection
by: Ruamviboonsuk V, et al.
Published: (2025-02-01)

Intravitreal injections: antibiotics or antiseptics?
by: I. E. Ioshin, et al.
Published: (2018-10-01)

Effect of multiple intravitreal injections of conbercept on the cornea in patients with branch retinal vein occlusion-induced macular edema
by: Gaixia Zhai, et al.
Published: (2025-06-01)

Assessment of effect of intravitreal ranibizumab injection on the ocular blood flow in patients with neovascular age-related macular degeneration
by: V. V. Neroev, et al.
Published: (2014-07-01)

Effects of switching from intravitreal injection of aflibercept to faricimab on ocular blood flow in patients with diabetic macular edema
by: Yoshinari Saima, et al.
Published: (2024-06-01)

The psychological status of patients with delayed intravitreal injection for treatment of diabetic macular edema due to the COVID-19 pandemic.
by: Mohamad Azlan Zaini, et al.
Published: (2023-01-01)

Effect of combined mature cataract surgery and intravitreal ranibizumab injection in eyes with pre-existing diabetic macular edema
by: Yao Shen, et al.
Published: (2025-08-01)

Risk factors and Response of Branch Retinal Vein Occlusion induced Macular Edema to intravitreal injections of Triamcinolone and Bevacizumab
by: Singhai Prakhar, et al.
Published: (2017-07-01)

Choroidal Response to Intravitreal Bevacizumab Injections in Treatment-Naïve Macular Neovascularization Secondary to Chronic Central Serous Chorioretinopathy
by: David Rabinovitch, et al.
Published: (2024-12-01)

A Prospective Interventional Study to Find the Effectivity of Razumab by Measuring Macular Oedema before and after Intravitreal Injection
by: V.K Malathi, et al.
Published: (2025-01-01)

Macular edema in Wyburn-Mason syndrome: Resolution with anti-VEGF intravitreal injections. Case report and review of the literature
by: Nathan Hupin, et al.
Published: (2024-12-01)

Exploring Factors behind Patient Nonadherence to Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Macular Diseases
by: Efrat Naaman, et al.
Published: (2025-01-01)

Intravitreal bevacizumab for neovascular age-related macular degeneration
by: Junn R. Pajarillo, MD, et al.
Published: (2009-12-01)

Pars Plana Vitrectomy versus Intravitreal Injection of Ranibizumab in the Treatment of Diabetic Macular Edema Associated with Vitreomacular Interface Abnormalities
by: Hassan Elkayal, et al.
Published: (2021-01-01)

Sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic macular edema and the need for intravitreal injection
by: Yoo-Ri Chung, et al.
Published: (2025-07-01)

Visual Field Loss Progression after Macular Hole Surgery
by: Gian Marco Tosi, et al.
Published: (2009-01-01)